Xencor (XNCR) Total Debt (2023 - 2026)
Xencor (XNCR) posted quarterly Total Debt of $108.5 million for Q1 2026, down 29.7% year-over-year from $154.4 million in Q1 2025, and down 9.37% quarter-over-quarter from $119.7 million in Q4 2025.
Analysis
Xencor (XNCR) Total Debt (2023 - 2026) Analysis & Trends
Xencor (XNCR) has reported Total Debt for 4 consecutive years, with $108.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Debt fell 29.7% year-over-year to $108.5 million; the TTM figure through Mar 2026 stood at $108.5 million (down 29.7% YoY), while the FY2025 annual figure was $119.7 million, down 26.81% from the prior year.
- Total Debt eased to $108.5 million in Q1 2026 per XNCR's latest filing, from $119.7 million in the prior quarter.
- Across five years, Total Debt topped out at $189.5 million in Q4 2023 and bottomed at $108.5 million in Q1 2026.
- Historically, Total Debt has averaged $155.2 million across 4 years, with a median of $159.0 million in 2024.
- Annual changes were most pronounced in 2024 — Total Debt fell 13.66% — and 2026, when it retreated 29.7%.
- Xencor's Total Debt stood at $189.5 million in 2023, then fell by 13.66% to $163.6 million in 2024, then retreated by 26.81% to $119.7 million in 2025, then fell by 9.37% to $108.5 million in 2026.
- Business Quant data shows XNCR's Total Debt at $108.5 million in Q1 2026, $119.7 million in Q4 2025, and $133.1 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 591.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 1.07 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 9.34 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 546.77 Mn |
| 10 | Xencor | 2.02 Bn | 1.65 Bn | - | 104.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 104.90 Mn |
| Mar 31, 2026 | 108.53 Mn |
| Dec 31, 2025 | 119.75 Mn |
| Sep 30, 2025 | 133.14 Mn |
| Jun 30, 2025 | 145.02 Mn |
| Mar 31, 2025 | 154.38 Mn |
| Dec 31, 2024 | 163.61 Mn |
| Sep 30, 2024 | 172.80 Mn |
| Jun 30, 2024 | 179.76 Mn |
| Mar 31, 2024 | 185.10 Mn |
| Dec 31, 2023 | 189.48 Mn |